SecBot SecBot
PRESS-RELEASE ·Filed Nov 16, 2026
DA

DAVI

Davion Healthcare Plc
NEUTRAL
Impact 4/10
Horizonweeks Processed5d 23h ago WireGlobeNewswire
Press release · M&A
Actionable Insight • Neutral

Monitor progress of due diligence and definitive agreement execution. The deal is small relative to Davion's market cap but could provide a revenue base if completed. Watch for financing details and regulatory approvals.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$1.02
T+0 close · Nov 16, 2026 · via day close
Latest settled
+0.98%
T+1 · $1.03
Vs SPY
+2.00%
α at T+1
Next horizon
T+5
in 23h
  1. T+0 · Nov 16 $1.02entry
  2. T+1 · 5d ago +0.98%α +2.00% · $1.03
  3. T+4 · todayOpen
  4. T+5 · in 23h Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Davion Healthcare announced a proposed acquisition of 14 Independence Care homecare businesses across 10 US states for up to $10 million in cash, shares, and earnouts. The target businesses generated approximately $17 million in combined 2025 revenue, and the deal is subject to due diligence, definitive agreements, and regulatory approvals.

Key Financial Metrics

Deal Value
$10.0M

Key Facts

  • Davion Healthcare to acquire 14 Independence Care homecare businesses across 10 US states.
  • Total consideration up to US$10 million: $4.5M cash at signing, $3.5M cash at milestone, $1M in shares (approx. 76,923 shares at $13.00/share), and up to $1M cash earnouts.
  • Target businesses generated combined revenues of approximately US$17 million in 2025.
  • Transaction subject to due diligence, definitive agreements, and regulatory approvals.
  • Target closing for definitive agreement on or before 31 December 2026; milestone payment targeted by 30 June 2027.

Financial Impact

Up to $10 million total consideration vs. $17 million target revenue; Davion market cap ~$30M.

revenuedilution

Risk Factors

  • Transaction may not close due to due diligence findings or regulatory hurdles.
  • Consideration includes shares, causing dilution for existing shareholders.
  • Earnout targets may not be met, reducing total consideration but also indicating underperformance.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3403426

US Market Status

Market Closed · Opens Mon (25h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026